JAK3, Janus kinase 3, 3718

N. diseases: 194; N. variants: 28
Disease: Nasal Type Extranodal NK/T-Cell Lymphoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0392788
Disease: Nasal Type Extranodal NK/T-Cell Lymphoma
Nasal Type Extranodal NK/T-Cell Lymphoma 		0.320 AlteredExpression disease BEFREE JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/T‑cell lymphoma, nasal type. 31002364 2019
CUI: C0392788
Disease: Nasal Type Extranodal NK/T-Cell Lymphoma
Nasal Type Extranodal NK/T-Cell Lymphoma 		0.320 GeneticVariation disease BEFREE Novel JAK3 mutations are oncogenic and druggable in NTCL. 28284718 2017
CUI: C0392788
Disease: Nasal Type Extranodal NK/T-Cell Lymphoma
Nasal Type Extranodal NK/T-Cell Lymphoma 		0.320 Biomarker disease CTD_human JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma. 23689514 2014
CUI: C0392788
Disease: Nasal Type Extranodal NK/T-Cell Lymphoma
Nasal Type Extranodal NK/T-Cell Lymphoma 		0.320 Biomarker disease CTD_human Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma. 22705984 2012